AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results

ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended December 31, 2021. Recent Highlights Signed research collaboration with the University of California, Irvine (UCI) to explore…